DK240889A - S-enantiomere glutaramidderivater og deres anvendelse som laegemidler samt farmaceutiske praeparater indeholdende disse forbindelser - Google Patents

S-enantiomere glutaramidderivater og deres anvendelse som laegemidler samt farmaceutiske praeparater indeholdende disse forbindelser Download PDF

Info

Publication number
DK240889A
DK240889A DK240889A DK240889A DK240889A DK 240889 A DK240889 A DK 240889A DK 240889 A DK240889 A DK 240889A DK 240889 A DK240889 A DK 240889A DK 240889 A DK240889 A DK 240889A
Authority
DK
Denmark
Prior art keywords
pharmaceutical
enantiomeric
compounds
preparations containing
pharmaceutical preparations
Prior art date
Application number
DK240889A
Other languages
English (en)
Other versions
DK172032B1 (da
DK240889D0 (da
Inventor
John Christopher Danilewics
Michael Trevelyan Williams
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of DK240889D0 publication Critical patent/DK240889D0/da
Publication of DK240889A publication Critical patent/DK240889A/da
Application granted granted Critical
Publication of DK172032B1 publication Critical patent/DK172032B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/40—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/16—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
    • C07C233/17—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • C07C233/18—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of an acyclic saturated carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/08—One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Detergent Compositions (AREA)
  • Cosmetics (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Hydrogenated Pyridines (AREA)
DK240889A 1988-05-19 1989-05-18 (S)-enantiomere glutaramidderivater og disse forbindelser til anvendelse som lægemidler samt farmaceutiske præparater indeholdende disse forbindelser og (S)-enantiomere glutarsyrederivater, der er anvendelige som mellemprodukter ved fremstilling af disse forbindelser DK172032B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB888811873A GB8811873D0 (en) 1988-05-19 1988-05-19 Therapeutic agents
GB8811873 1988-05-19

Publications (3)

Publication Number Publication Date
DK240889D0 DK240889D0 (da) 1989-05-18
DK240889A true DK240889A (da) 1989-11-20
DK172032B1 DK172032B1 (da) 1997-09-22

Family

ID=10637176

Family Applications (1)

Application Number Title Priority Date Filing Date
DK240889A DK172032B1 (da) 1988-05-19 1989-05-18 (S)-enantiomere glutaramidderivater og disse forbindelser til anvendelse som lægemidler samt farmaceutiske præparater indeholdende disse forbindelser og (S)-enantiomere glutarsyrederivater, der er anvendelige som mellemprodukter ved fremstilling af disse forbindelser

Country Status (29)

Country Link
EP (1) EP0342850B1 (da)
JP (1) JPH072699B2 (da)
KR (1) KR920000561B1 (da)
CN (1) CN1015361B (da)
AT (1) ATE76399T1 (da)
AU (1) AU602813B2 (da)
CA (1) CA1331197C (da)
CS (1) CS274502B2 (da)
DD (1) DD283772A5 (da)
DE (1) DE68901582D1 (da)
DK (1) DK172032B1 (da)
EG (1) EG19007A (da)
ES (1) ES2037418T3 (da)
FI (1) FI93541C (da)
GB (1) GB8811873D0 (da)
GR (1) GR3004968T3 (da)
HU (1) HU205067B (da)
IE (1) IE60724B1 (da)
IL (1) IL90267A (da)
MX (1) MX16067A (da)
MY (1) MY104735A (da)
NO (1) NO173647C (da)
NZ (1) NZ229186A (da)
PH (1) PH26740A (da)
PL (1) PL154813B1 (da)
PT (1) PT90584B (da)
SU (1) SU1766251A3 (da)
YU (1) YU47973B (da)
ZA (1) ZA893696B (da)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8812597D0 (en) * 1988-05-27 1988-06-29 Pfizer Ltd Therapeutic agents
GB8820844D0 (en) * 1988-09-05 1988-10-05 Pfizer Ltd Therapeutic agents
GB9000725D0 (en) * 1990-01-12 1990-03-14 Pfizer Ltd Therapeutic agents
DE69300826T2 (de) * 1993-09-22 1996-04-18 Pfizer Res & Dev Hydrierung.
US7468390B2 (en) 2002-01-17 2008-12-23 Novartis Ag Methods of treatment and pharmaceutical composition
AR057882A1 (es) 2005-11-09 2007-12-26 Novartis Ag Compuestos de accion doble de bloqueadores del receptor de angiotensina e inhibidores de endopeptidasa neutra
US8993631B2 (en) * 2010-11-16 2015-03-31 Novartis Ag Method of treating contrast-induced nephropathy
MA37850A1 (fr) 2012-08-24 2018-07-31 Novartis Ag Inhibiteurs de nep pour le traitement de maladies caractérisées par un agrandissement atrial ou une remodélisation atriale
WO2017033128A1 (en) 2015-08-25 2017-03-02 Novartis Ag Biphenyl-substitued 4-amino-butyric acid derivatives and their use in the synthesis of nep inhibitors
WO2017072636A1 (en) 2015-10-29 2017-05-04 Cadila Healthcare Limited Pharmaceutical synergistic combination

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR880007441A (ko) * 1986-12-11 1988-08-27 알렌 제이.스피겔 스피로-치환된 글루타르아미드 이뇨제

Also Published As

Publication number Publication date
SU1766251A3 (ru) 1992-09-30
ES2037418T3 (es) 1993-06-16
IE60724B1 (en) 1994-08-10
EP0342850A1 (en) 1989-11-23
YU47973B (sh) 1996-08-13
MX16067A (es) 1993-10-01
CN1015361B (zh) 1992-02-05
DD283772A5 (de) 1990-10-24
FI93541B (fi) 1995-01-13
IL90267A0 (en) 1989-12-15
CN1037704A (zh) 1989-12-06
NO892002D0 (no) 1989-05-18
CA1331197C (en) 1994-08-02
YU102289A (en) 1991-06-30
JPH072699B2 (ja) 1995-01-18
NO173647B (no) 1993-10-04
HUT53596A (en) 1990-11-28
ZA893696B (en) 1990-12-28
PH26740A (en) 1992-09-28
CS296589A2 (en) 1990-09-12
JPH0222256A (ja) 1990-01-25
KR900017993A (ko) 1990-12-20
NO173647C (no) 1994-01-12
EG19007A (en) 1994-11-30
NZ229186A (en) 1990-10-26
DK172032B1 (da) 1997-09-22
PL154813B1 (en) 1991-09-30
PT90584A (pt) 1989-11-30
AU602813B2 (en) 1990-10-25
DK240889D0 (da) 1989-05-18
FI892386A (fi) 1989-11-20
DE68901582D1 (de) 1992-06-25
FI892386A0 (fi) 1989-05-18
CS274502B2 (en) 1991-04-11
AU3490489A (en) 1989-11-23
IL90267A (en) 1993-08-18
HU205067B (en) 1992-03-30
GB8811873D0 (en) 1988-06-22
FI93541C (fi) 1995-04-25
MY104735A (en) 1994-05-31
PL279491A1 (en) 1989-11-27
PT90584B (pt) 1994-09-30
NO892002L (no) 1989-11-20
ATE76399T1 (de) 1992-06-15
GR3004968T3 (da) 1993-04-28
KR920000561B1 (ko) 1992-01-16
IE891613L (en) 1989-11-19
EP0342850B1 (en) 1992-05-20

Similar Documents

Publication Publication Date Title
DK590787D0 (da) Cephalosporinsulfonforbindelse, fremgangsmaade og mellemprodukt til fremstilling deraf samt farmaceutisk praeparat indeholdende en saadan forbindelse
NO894417L (no) Bu-3608 fa-1 og fa-2, fremgangsmaate til fremstilling derav, alkylderivater derav samt farmasoeytiske preparater inneholdende bu-3608 fa-1, fa-2 eller alkylderivater derav.
DK240889A (da) S-enantiomere glutaramidderivater og deres anvendelse som laegemidler samt farmaceutiske praeparater indeholdende disse forbindelser
AU6700286A (en) Use of antidotal amides for herbicidal compositions of sulphonic urea derivatives
PT91203A (pt) Processo para a preparacao de novos derivados de antibioticos bu-3608 e de composicoes farmaceuticas que os contem
DE3688087T2 (de) Cephemverbindungen, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische praeparate.
NO884005D0 (no) Fluorerte derivater av aminosyrer saerlig for bruk som oveflateaktive midler.
ES2045067T3 (es) Procedimiento para preparar nuevos compuestos de tiazol.
DK0571243T3 (da) Thiochromanderivater, fremgangsmåder til fremstilling heraf samt farmaceutiske midler indeholdende d isse
ATE118215T1 (de) Cephalosporinderivate, verfahren zu ihrer herstellung, pharmazeutische präparate und zwischenverbindungen.
FI890678A0 (fi) Analogiamenetelmä terapeuttisesti käyttökelpoisten 1,3-dioksaanialkeenihappojohdannaisten valmistamiseksi
DK424888D0 (da) Naphthothiazepinderivater, fremgangsmaade til fremstilling deraf samt farmaceutiske praeparater indeholdende saadanne derivater
WO1987004435A3 (en) Xanthine compounds
AU3620089A (en) New process for the preparation of n-(23-vinblastinoyl) derivatives of 1-amino-methyl-phosphonic acid
ES2039270T3 (es) Derivados de gamma-l-glutamil-4-nitroanilida y procedimiento para determinar actividad de gamma-gtp utilizandolos.
DE69011174D1 (de) Catecholaminester.
FI921238A0 (fi) Välituotteina käytettävät N'-alkoksi- tai N'-aralkyylioksi-N6-syano-griseoliinihapon johdannaiset

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PBP Patent lapsed

Country of ref document: DK